EAU RISK GROUPS APPLIED ON PATIENTS TREATED WITH RADICAL PROSTATECTOMY - ANALYSIS OF PATHOLOGY SPECIMENS AND PATIENT SURVIVAL

Purpose: The European Association of Urology (EAU) classifies patients with prostate cancer into three risk groups - low-risk, intermediate- and high-risk depending on the probability of biochemical progression after treatment with curative intent (either radical prostatectomy or radiotherapy). The...

Full description

Bibliographic Details
Main Author: Boyan Lazarov
Format: Article
Language:English
Published: Peytchinski Publishing 2024-02-01
Series:Journal of IMAB
Subjects:
Online Access:https://www.journal-imab-bg.org/issues-2024/issue1/2024vol30-issue1-5392-5396.pdf
_version_ 1797292658293473280
author Boyan Lazarov
author_facet Boyan Lazarov
author_sort Boyan Lazarov
collection DOAJ
description Purpose: The European Association of Urology (EAU) classifies patients with prostate cancer into three risk groups - low-risk, intermediate- and high-risk depending on the probability of biochemical progression after treatment with curative intent (either radical prostatectomy or radiotherapy). The aim of the present study is to analyze our experience with patients who underwent radical prostatectomy and to look for the relationship between the pathological results from the operation and the distribution of patients into risk groups. Material/Methods: A single-center, non-interventional study was conducted. The study was performed after analysis of patients undergoing radical prostatectomy (either open or laparoscopic) at the Clinic of Urology in St. Anna Hospital in Varna. The number of patients available for analysis was 201. Data were analyzed with IBM SPSS version 23. Results: We found that high-risk patients had unfavorable results from the examination of the pathology specimens- patients with pT3a and pT3b were more often from the high-risk group. High-risk patients were also at increased risk of PSA progression and development of distant metastases. Conclusions: The EAU-risk groups will probably undergo changes connected with the improved methods for the diagnosis of prostate cancer. But still, it is a valid tool which correctly predicts the unfavorable pathology of the removed specimen and also the risk of biochemical progression after radical prostatectomy.
first_indexed 2024-03-07T19:59:39Z
format Article
id doaj.art-0b03da361a9d4efbb232f4bebd7b4629
institution Directory Open Access Journal
issn 1312-773X
language English
last_indexed 2024-03-07T19:59:39Z
publishDate 2024-02-01
publisher Peytchinski Publishing
record_format Article
series Journal of IMAB
spelling doaj.art-0b03da361a9d4efbb232f4bebd7b46292024-02-28T09:57:04ZengPeytchinski PublishingJournal of IMAB1312-773X2024-02-013015392539610.5272/jimab.2024301.5392EAU RISK GROUPS APPLIED ON PATIENTS TREATED WITH RADICAL PROSTATECTOMY - ANALYSIS OF PATHOLOGY SPECIMENS AND PATIENT SURVIVALBoyan Lazarov0https://orcid.org/0000-0002-5167-6022Clinic of Urology, Department of Surgery, Faculty of Medicine, MHAT "Sveta Anna-Varna", Medical University-Varna, Bulgaria.Purpose: The European Association of Urology (EAU) classifies patients with prostate cancer into three risk groups - low-risk, intermediate- and high-risk depending on the probability of biochemical progression after treatment with curative intent (either radical prostatectomy or radiotherapy). The aim of the present study is to analyze our experience with patients who underwent radical prostatectomy and to look for the relationship between the pathological results from the operation and the distribution of patients into risk groups. Material/Methods: A single-center, non-interventional study was conducted. The study was performed after analysis of patients undergoing radical prostatectomy (either open or laparoscopic) at the Clinic of Urology in St. Anna Hospital in Varna. The number of patients available for analysis was 201. Data were analyzed with IBM SPSS version 23. Results: We found that high-risk patients had unfavorable results from the examination of the pathology specimens- patients with pT3a and pT3b were more often from the high-risk group. High-risk patients were also at increased risk of PSA progression and development of distant metastases. Conclusions: The EAU-risk groups will probably undergo changes connected with the improved methods for the diagnosis of prostate cancer. But still, it is a valid tool which correctly predicts the unfavorable pathology of the removed specimen and also the risk of biochemical progression after radical prostatectomy.https://www.journal-imab-bg.org/issues-2024/issue1/2024vol30-issue1-5392-5396.pdfoverall survivalpsa-progressionlymph node metastasesextraprostatic extensionseminal vesicle involvement
spellingShingle Boyan Lazarov
EAU RISK GROUPS APPLIED ON PATIENTS TREATED WITH RADICAL PROSTATECTOMY - ANALYSIS OF PATHOLOGY SPECIMENS AND PATIENT SURVIVAL
Journal of IMAB
overall survival
psa-progression
lymph node metastases
extraprostatic extension
seminal vesicle involvement
title EAU RISK GROUPS APPLIED ON PATIENTS TREATED WITH RADICAL PROSTATECTOMY - ANALYSIS OF PATHOLOGY SPECIMENS AND PATIENT SURVIVAL
title_full EAU RISK GROUPS APPLIED ON PATIENTS TREATED WITH RADICAL PROSTATECTOMY - ANALYSIS OF PATHOLOGY SPECIMENS AND PATIENT SURVIVAL
title_fullStr EAU RISK GROUPS APPLIED ON PATIENTS TREATED WITH RADICAL PROSTATECTOMY - ANALYSIS OF PATHOLOGY SPECIMENS AND PATIENT SURVIVAL
title_full_unstemmed EAU RISK GROUPS APPLIED ON PATIENTS TREATED WITH RADICAL PROSTATECTOMY - ANALYSIS OF PATHOLOGY SPECIMENS AND PATIENT SURVIVAL
title_short EAU RISK GROUPS APPLIED ON PATIENTS TREATED WITH RADICAL PROSTATECTOMY - ANALYSIS OF PATHOLOGY SPECIMENS AND PATIENT SURVIVAL
title_sort eau risk groups applied on patients treated with radical prostatectomy analysis of pathology specimens and patient survival
topic overall survival
psa-progression
lymph node metastases
extraprostatic extension
seminal vesicle involvement
url https://www.journal-imab-bg.org/issues-2024/issue1/2024vol30-issue1-5392-5396.pdf
work_keys_str_mv AT boyanlazarov eauriskgroupsappliedonpatientstreatedwithradicalprostatectomyanalysisofpathologyspecimensandpatientsurvival